WO2019202410A1 - Non invasive point of care diagnostics for sickle cell disease - Google Patents
Non invasive point of care diagnostics for sickle cell disease Download PDFInfo
- Publication number
- WO2019202410A1 WO2019202410A1 PCT/IB2019/050846 IB2019050846W WO2019202410A1 WO 2019202410 A1 WO2019202410 A1 WO 2019202410A1 IB 2019050846 W IB2019050846 W IB 2019050846W WO 2019202410 A1 WO2019202410 A1 WO 2019202410A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wavelength
- sickle cell
- absorbance
- cell disease
- magnetic field
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0431—Portable apparatus, e.g. comprising a handle or case
Definitions
- the present invention relates in general to the non-invasive diagnostics for sickle cell disease. More specifically, the invention relates to a non-invasive portable device and method that utilizes a specially designed algorithm to identify the sickle cell disease based on different wavelength absorbance responses from the human finger tissue.
- Sickle-cell disease is a group of blood disorders typically inherited from person's parents. Sickle cell disease may occur from the birth stage itself, but disease symptoms cannot be observed in most of the infants until they are few months old. Symptoms of the sickle cell disease are not similar for everyone. In some people, they are mild and in others they are severe and require hospitalization. Millions of people are affected by SCD worldwide such as sub-saharan Africa, central India, and eastern Brazil. Every year, six million children are born with SCD or sickle cell trait. Up to 90% of the newborns with SCD die soon after their birth from this disease, if undiagnosed.
- Sickle-cell disease occurs when a person inherits two abnormal copies of the haemoglobin gene, one from each parent.
- SCD is one of the most common inherited blood disorders in the world. SCD is caused by the inheritance of two copies of the gene encoding hemoglobin S, a protein that results from a missense mutation in the b-globin sub unit of hemoglobin A.
- sickle cell disease inherited group of disorders, red blood cells contort into a sickle shape.
- the cells die early, leaving a shortage of healthy red blood cells which is referred as sickle cell anemia and the cells can block blood flow causing pain which is referred as sickle cell crisis.
- the symptoms caused by the sickle cell disease include infections, pain and fatigue.
- a typical measurement procedure for SCD detection involves invasive method where the extraction of fluids or cells are required from the human.
- the methods existed for the characterization of the hemoglobin disorders, for example the sickle cell disease include electrophoresis, high performance liquid chromatography (HPLC) and PCR based techniques. These techniques require well trained staff with well-maintained equipment with reasonable laboratory facilities. Currently the involved diagnostic methodologies are expensive, time-consuming and cannot be performed at the point-of-care.
- the primary objective of the invention is to provide a non-invasive diagnostic device to identify sickle cell disease which can be performed at the point of care.
- the other objective of the invention is to provide a portable and battery operated device for the diagnostics of the sickle cell disease.
- the other objective of the invention is to detect the SCD using multi -wavelength radiating means through which light beam can be passed through the human finger tissue.
- Another objective of the invention is to detect different wavelength absorbance responses from the human finger tissue at a varying magnetic field.
- Another objective of the invention is to provide a special algorithm for accurate and rapid evaluation of the disease detection.
- Another objective of the invention is to implement an algorithm by the controlling means of the device to process the absorbance responses from the human finger tissue and evaluate the parameters.
- Another objective of the invention is to facilitate a cost-effective and less time consuming SCD detection through which mass screening of even rural population can be accomplished without affecting their routine work.
- Another objective of the invention is to provide an accurate and amplified output signal using an amplifying and filtering means.
- the invention proposes a non invasive point of care diagnostics for sickle cell disease.
- the following presents a simplified summary in order to provide a basic understanding of some aspects of the claimed subject matter. This summary is not an extensive overview. It is not intended to identify key /critical elements or to delineate the scope of the claimed subject matter. Its sole purpose is to present some concepts in a simplified form as a prelude to the more detailed description that is presented later.
- the invention in general relates to a device and a method for identifying the sickle cell disease.
- the device utilizes a multi-wavelength radiating means and a magnetic means either separately or simultaneously for subsequent determination of the disease.
- the invention relates to a non-invasive portable device for the direct measurement of the SCD through the absorbance levels of the light beam at different wavelengths.
- the absorbance levels of the light beam at different wavelengths are collected by applying varying magnetic field upon the tissue through the magnetic means.
- the varying magnetic field is accomplished in two conditions i.e., magnetic field ON condition and magnetic field OFF condition.
- the portable non-invasive device comprises, a multi-wavelength radiating means, a photo detecting means, a wavelength selector, a magnetic means such as an electromagnetic ring and an electromagnet excitation circuit, a pre-amplifier, a sampling and holding means, an amplifying and filtering means, a controlling means and a display.
- the multi-wavelength radiating means emanates light through the human finger tissue with at least one wavelength which is accomplished by the controlling means. At least one wavelength is selected through a wavelength selector.
- the magnetic means is configured to apply a varying magnetic field on the human finger tissue i.e., the magnetic field is applied upon the tissue through the electromagnetic ring and the electromagnet excitation circuit.
- the absorbance response of light having said at least one wavelength is detected by the photo detecting means.
- the absorbance response of light at different wavelengths are collected during ON condition and OFF condition of the magnetic field.
- the detected absorbance response of light from the photo detecting means is pre-amplified by means of a pre-amplifier.
- the obtained output is separated into corresponding channel output through the sampling and holding means. Further, the channel output is processed by amplifying and filtering using amplifying and filtering means and is sent to the controlling means.
- the controlling means manipulates the multi-wavelength radiating means and the magnetic means and then evaluates the disease parameters through an algorithm.
- the procedure of detecting sickle cell disease using non-invasive device comprises emanating light through the human finger tissue with at least one wavelength, applying a varying magnetic field on the human finger tissue, detecting absorbance response of light having said at least one wavelength, separating different absorbance response wavelengths into corresponding channels, processing channel output by amplifying and filtering, evaluating disease parameters through an algorithm and displaying evaluated diagnosis response.
- a specially designed algorithm for evaluating disease parameters comprises receiving light absorbance signals from a human finger tissue, computing ratios of different wavelength absorbance responses at varying magnetic field, considering the ratios of different wavelength absorbance responses as parametric responses of the human finger tissue, multiplying the parametric responses with scale factors and then adding, evaluating a critical number and finally comparing the critical number with a threshold value to confirm the disease.
- the exemplary device is configured with the components as per the function described above, whereas the device can be further configured with other components or circuits or modules that aid either in the light transmission technique or absorption technique or evaluation technique of the disease.
- the algorithm which is implemented above by the controlling means for the evaluation of the parameters can be further simplified or modified or extended for the enhanced evaluation.
- the device apart from employing the disclosed components, can be equipped with other extended components that adds supplemental features to the device.
- Fig. 1 depicts a schematic form of a device 100 for non-invasive detection of the sickle cell disease according to an embodiment of the invention.
- Fig. 2 illustrates an exemplary procedure of sickle cell disease detection using noninvasive device.
- FIG. 3 illustrates an exemplary designed algorithm for evaluating disease parameters according to an embodiment of the invention.
- Fig. 1 depicts a schematic form of a device 100 for non-invasive detection of the sickle cell disease.
- the device identifies the disease basing on different absorbance levels of the light beam at different wavelengths passing through the human finger tissue.
- the device 100 mainly consists of a multi-wavelength radiating means 101, a photo detecting means 102, a wavelength selector 103, a magnetic means such as an electromagnetic ring 104 and an electromagnet excitation circuit 105, a pre-amplifier 106, a sampling and holding means (S&H) 107, an amplifying and filtering means 108, a controlling means 109 and a display 110.
- S&H sampling and holding means
- the multi-wavelength radiating means 101 may comprise a halogen bulb, LED or diode laser and thereof.
- the invention considers surface mount device (SMD) LEDs that are mounted in a specifically designed LED holder. This helps in emanating light as a narrow beam and which is then projected out. This projected light beam is passed over a human finger tissue as shown in fig. 1. The light beam reached out from the other side of the finger is detected by the photo detecting means 102.
- the photo detecting means 102 can be selected, based on the range of wavelengths that are chosen and also on the response time.
- each LED of the multi-wavelength radiating means 101 is glown for a short time interval with a selected wavelength using the wavelength selector 103.
- the output from the photo detecting means 102 is amplified suitably, by means of a pre-amplifier 106.
- the output from the pre-amplifier 106 in turn is provided to the output channel which is selected and enabled by the corresponding activation of a particular wavelength LED.
- the separation of the different wavelength responses of the tissue to a corresponding channel can be achieved by placing an S&H circuit 107 at the input stage of each channel.
- the S&H circuit 107 of a corresponding channel is enabled, when the particular wavelength LED is glown. Therefore, the channel output is the absorbance response of the tissue for that particular wavelength.
- the output is the absorbance response of the tissue for that particular wavelength.
- the S&H circuit 107 is further amplified and filtered using the amplifying and filtering means 108. This removes the switching noise and other noise signals.
- the channels are designed to have the similar time response characteristics.
- the channel outputs are provided to the controlling means 109 as analog signals. These analog signals are sampled by the controlling means 109 to perform the analysis.
- the controlling means 109 controls the switching of different LEDs of the multi wavelength radiating means 101 and enables respective S&H circuits.
- the controlling means 109 is also responsible to control the electromagnetic ring 104 through electromagnet excitation circuit 105 to provide two different conditions i.e., ON and OFF.
- ON condition the controlling means 109 applies magnetic field over the tissue and collects the tissue absorbance at different wavelengths in a time synchronized manner. The same process continues to collect the tissue absorbance during the OFF condition, where the magnetic field is not applied.
- the controlling means 109 analyses the tissue absorbance signals by applying a specially designed algorithm and obtains certain parameters which are subsequently used to identify the sickle cell disease.
- the controlling means 109 is further provided with a closed feedback loop to obtain gain control.
- the evaluated diagnosis response is displayed on the display 110 which can be an LCD or visible diode display.
- Fig. 2 represents a procedure of detecting sickle cell disease using non-invasive device 200.
- the procedure comprises emanating light through the human finger tissue with at least one wavelength at step 201.
- the light is emanated by means of the multi-wavelength radiating means.
- a varying magnetic field is applied on the human finger tissue through an electromagnetic ring.
- absorbance response of light from the tissue with at least one wavelength is detected.
- different absorbance response wavelengths are separated into corresponding channels using a sampling and holding means.
- the channel output is further processed by amplifying and filtering.
- the disease parameters are evaluated using an algorithm and finally the evaluated diagnosis response is displayed on the display at step 207.
- an algorithm for evaluating disease parameters is depicted in fig. 3.
- the controlling means receives the channel outputs of the light absorbance signals from the human finger tissue.
- the ratios of different wavelength absorbance responses are computed at varying magnetic field i.e., in two conditions of the magnetic field excitation given to the electromagnetic ring. For example, the wavelength absorbance responses are measured when the magnetic field is applied (ON condition) and also when the magnetic field is removed (OFF condition).
- the ratios of different wavelength absorbance responses are considered as parametric responses of the human finger tissue.
- the parameters are multiplied with scale factors and then the multiplied results are added.
- a critical number is evaluated.
- the critical number is compared with a threshold value.
- the threshold value can be obtained from the normal and the sickle cell readings.
- the sickle cell disease is confirmed if the critical number is more than the threshold value. Otherwise the sickle cell disease is rejected and the person is considered normal.
- the SCD disease can also be detected by considering other tissues such as a toe, an earlobe apart from the finger as mentioned in the complete description.
- the magnetic field applied by the electromagnetic ring can also be accomplished by the magnetic plates as well.
- Output from the controlling means can also be provided with an audio-visual alarm for real-time results. Further, a provision can be facilitated to store the information electronically.
- the proposed device is a non-invasive diagnostics device to identify sickle cell disease which can be performed at the point of care.
- the device is a portable and battery operated through which the detection of the SCD can be accomplished using multi 10 wavelength radiating means.
- the output of different wavelength absorbance responses at a varying magnetic field is noted and computed with a special algorithm.
- the device facilitates a cost-effective and less time consuming SCD detection through which the mass screening of even rural population can be accomplished without affecting their routine work.
- the invention facilitates an environmental friendly device which can be easily operated by the normal staff without requiring any laboratory facility.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201841005300 | 2018-04-18 | ||
IN201841005300 | 2018-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019202410A1 true WO2019202410A1 (en) | 2019-10-24 |
Family
ID=68239978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2019/050846 WO2019202410A1 (en) | 2018-04-18 | 2019-02-03 | Non invasive point of care diagnostics for sickle cell disease |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2019202410A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630990B2 (en) * | 2001-06-05 | 2003-10-07 | Abbott Laboratories | Optical method and apparatus for red blood cell differentiation on a cell-by-cell basis, and simultaneous analysis of white blood cell differentiation |
US20100198037A1 (en) * | 2009-01-30 | 2010-08-05 | Cole Steven W | Feedback sensor for real-time management of sickle cell disease |
EP3076333A1 (en) * | 2015-04-02 | 2016-10-05 | Siemens Aktiengesellschaft | Analysis method for classification of a test dispersion to determine the presence of sickle cell anaemia |
-
2019
- 2019-02-03 WO PCT/IB2019/050846 patent/WO2019202410A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630990B2 (en) * | 2001-06-05 | 2003-10-07 | Abbott Laboratories | Optical method and apparatus for red blood cell differentiation on a cell-by-cell basis, and simultaneous analysis of white blood cell differentiation |
US20100198037A1 (en) * | 2009-01-30 | 2010-08-05 | Cole Steven W | Feedback sensor for real-time management of sickle cell disease |
EP3076333A1 (en) * | 2015-04-02 | 2016-10-05 | Siemens Aktiengesellschaft | Analysis method for classification of a test dispersion to determine the presence of sickle cell anaemia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210364421A1 (en) | Method and apparatus for determining markers of health by analysis of blood | |
US8423104B2 (en) | Haemozoin detection | |
Naseer et al. | Raman spectroscopy based differentiation of typhoid and dengue fever in infected human sera | |
JP3248905B2 (en) | Method for analyzing biological substances having a water content | |
EP3282937A1 (en) | Method and apparatus for determining markers of health by analysis of blood | |
Ramani et al. | The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review | |
TW201208649A (en) | Apparatus and method for predicting a parameter in the blood stream of a subject | |
CN107148565A (en) | Method and system for detecting the pathogen in blood | |
Darshana et al. | Validation of the WHO hemoglobin color scale method | |
Theint et al. | Development of an optical biosensor for the detection of Trypanosoma evansi and Plasmodium berghei | |
Rochmanto et al. | Non-invasive hemoglobin measurement for anemia diagnosis | |
Sarkar et al. | Development and validation of a noncontact spectroscopic device for hemoglobin estimation at point-of-care | |
Verdonck et al. | Label-free phenotyping of peripheral blood lymphocytes by infrared imaging | |
Nirupa et al. | Non-invasive measurement of hemoglobin content in blood | |
Azarnoosh et al. | Assessment of photoplethysmography method in extraction of hemoglobin concentration | |
Ullah et al. | Evaluating the performance of multilayer perceptron algorithm for tuberculosis disease Raman data | |
US20060135869A1 (en) | System and method for measuring arterial vessels using near infrared spectroscopy at simultaneous multiple wavelengths | |
WO2019202410A1 (en) | Non invasive point of care diagnostics for sickle cell disease | |
CN103245650A (en) | Noninvasive diabetes detection device based on advanced glycation end product fluorescence spectrum | |
Srinivasan et al. | Optical absorbance-based rapid test for the detection of sickle cell trait and sickle cell disease at the point-of-care | |
FI92877B (en) | Method for measuring polarized fluorescence emissions | |
JP4065734B2 (en) | Physical examination method | |
US20170219568A1 (en) | Method and device for quality controlling a blood-based product | |
KR20160014866A (en) | A method and device for diagnosis of viral infection using tear drop | |
Yamani et al. | A proposed noninvasive point-of-care technique for measuring hemoglobin concentration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19789307 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19789307 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19789307 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 02.06.2021) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19789307 Country of ref document: EP Kind code of ref document: A1 |